Mirae Asset Global ETFs Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$122M Buy
133,812
+21,286
+19% +$21.6M 0.17% 130
2025
Q4
$121M Buy
112,526
+11,141
+11% +$10.7M 0.18% 125
2025
Q3
$77.1M Buy
101,385
+26,259
+35% +$19.5M 0.12% 173
2025
Q2
$58.6M Sell
75,126
-1,200
-2% -$932K 0.11% 195
2025
Q1
$63M Buy
76,326
+8,557
+13% +$7.12M 0.13% 167
2024
Q4
$52.3M Buy
67,769
+139
+0.2% +$115K 0.11% 197
2024
Q3
$59.9M Sell
67,630
-5,001
-7% -$4.5M 0.13% 157
2024
Q2
$65.8M Buy
+72,631
New +$58.1M 0.16% 144

Other funds holding LLY

Mirae Asset Global ETFs Holdings's LLY Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Eli Lilly (LLY) stake by 19% in Q1 2026, buying an estimated $21.6M and bringing the position to 133,812 shares worth $122M. The position accounts for 0.17% of the portfolio, ranked #130.

Mirae Asset Global ETFs Holdings first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 133,812 shares of Eli Lilly worth $122M as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 21,286 Eli Lilly shares in Q1 2026, an estimated $21.6M.
  • Eli Lilly made up 0.17% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #130 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.